Korro Bio, Inc. (KRRO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the 2026 Annual Meeting of Stockholders held on June 10, 2026. The registrant, Korro Bio, Inc., is a Delaware corporation with its principal executive offices in Cambridge, MA, and its common stock trades on The Nasdaq Capital Market under the symbol "KRRO."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders voted on three primary matters at the Annual Meeting:
- Election of Directors: Stockholders elected Nessan Bermingham and Rachel Meyers as Class I directors for three-year terms ending in 2029.
- Nessan Bermingham: 7,468,003 votes For; 1,576,660 votes Withheld; 1,875,955 Broker Non-Votes.
- Rachel Meyers: 7,368,284 votes For; 1,676,379 votes Withheld; 1,875,955 Broker Non-Votes.
- Executive Compensation: Stockholders approved the non-binding advisory vote on executive compensation.
- Results: 9,009,739 votes For; 27,988 votes Against; 6,936 Abstain; 1,875,955 Broker Non-Votes.
- Ratification of Auditors: Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Results: 10,917,621 votes For; 2,738 votes Against; 259 Abstain; 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future operations, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and the percentage of votes cast versus total shares to assess shareholder engagement levels.
- Confirm the specific terms of the three-year director tenure for the newly elected Class I directors.
- Review the full proxy statement for details on the executive compensation package that received advisory approval.
- Note that the report was signed by Ram Aiyar, who holds the titles of President, CEO, and Interim CFO.